Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FCN-338 by Fochon Pharmaceutical for Non-Hodgkin Lymphoma: Likelihood of Approval
FCN-338 is under clinical development by Fochon Pharmaceutical and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase...